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THE presence of aii iiiiiibitor of oncolvsis in the ascitic fluid from the Elirlicli
ascites carcinoma has been invoked previously (Hartveit, 1963b) to explain the
survival of this tumour oii homotransplaiitation. Lysed cells are present, in
early transplaiits of this tumour, when the proteiii conteilt of the ascites is low.
whiie thev are not found in later transplants in which the protein content has'
beeii sho-%vn to be higher. It was felt that the increase in the proteiii conteiit
might be respoiisible for this inhibition oflysis, particularly as the serum proteins
in general show ai-i iiihibitor action on haemolytic reactions (Ponder, 1948).
-NA-hich have beeii shown to be akin to the oncolytic reactioii (Hartveit, 1965).
As, from the above-meiitioiied studies, it seemedpossible that it is an inhibitor
of Ivsis rather than lack of complement that puts a stop to the lvtic reactioii
tn vtvo it was decided to iiivestigate the result of adding complement to the
tumour cells aiid testing the effect of tumour ascitic fluid on the oncolvtic reactioii
in vitro. Humai-i serum was used as the source of complement as tilis has beeii
iised in most of the work oii the oncolytic reaction (see Hartveit, 1965).
The effect of tumour ascitic fluid from tumour transplaiits of differeiit ages
-%vas tested with many sera, serum-cell conceiitrations ai-id on tumour trai-isplai-its
of different ageq. As the results were similai, in all cases oiilv specimen experi-
meiits will be reported here.
MATERIAL AND METHODS
The Ehrlich ascites carcinoma, the mice aiid the humaii sera used weresimilar
to those used in previous experimeiits (Hartveit, 1965a. b). A oiie in 20 sus-
pension of whole tumour ascites in phvsiological saline was used for the tumour
cell suspensioii. The ttiLmour cells were takeii from a pykiiotic transplaiit. i.e.
oiie that contaiiied iio lysed cells (Hartveit, 1963a). The humaii sera were used
either uiidiluted or after dilutioii in phvsiological saliiie. Tumour ascitic fluid
was obtained after removiiig the cells bv ceiitrifugatioii. This fluid was used
either fresh or after storage at -20' C. it was used whole or after dilutioii m-ith
physiological saline.
The cell-serum-ascitic fluid mixtures NN-ere made ul) iii the follom-ino, propor-
tioiis : I vol. serum (or serum dilutioii) to I vol. cell suspeiision to I vol. ascitic
fluid (or diluted ascitic fluid or saliiie), i.e. I : I : I in eacli case. Wet prepara-
tioiis were set up at 20' C. and at 37' C. as in the previous experimeiits aiid
examined for tumour cell lvsis, microscopicallv. a-t iiitervals for oiie hotir.
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EXPERIMENTAL PROCEDURE
Experiment I.-Four human sera were set up against tumour cells from a
5-day transplant. The effect of adding ascitic fluid from this 5-day transplant
and from a 12-day transplant was tested. Both ascitic fluids were used whole
and diluted I : 5.
Experiment II.-The effect of dilution of the serum was tested. The serum
that had shown the highest lytic activity in experiment I was chosen and tested
at I : 2) 1 : 4 and I : 8 dilution, against the two ascitic fluids in the dilutions used
above.
RESULTS
The findings are shown in Tables I and II.
TABLEI.-The Inhibitory Effect of Tumour Ascitic Fluid on the,
Oncolytic Reaction in Vitro
no lysis
± some lysis
+ complete lysis
Reactants (I : I : 1)
e .-A-
AF-ascitic fluid
Oncolytic activity
Temp. 'C.
r
A
20 37
Time (riiin.)
0 15 30 45 60 30 60
(1) saline
(2) 5-day AF
(3) 5-day (1 : 5)
(4) 12-day AF
(5) 12-day (I : 5)
1
3
4
5
Tumour
cell
suspension
1:20
Serum
-No.
I
2 1 : 20 1
2
3
4
5
1
2
3
4
5
1
2
3
4
5
3 1 : 20
4 1 : 20
-4-
-4-
Table I shows that, for example, with serum No. 1, I vol. of wliole serum
plus I vol. of tumour ceR suspension plus I vol. of sahne gave lysis after 15 min-
utes at 20' C. When whole ascitic flWd was substituted for sahne, lysis failed
to occur at 20' C. even after 60 minutes. Lysis occurred after 30 minutes at
37' C. with the 5-day fluid but was not present until 60 minutes had elapsed with the 12-day fluid. Thus the 12-day fluid was more inhibitory to the lytic reaction than the 5-day fluid. This finding is also demonstrated when the ascitie728 F. HARTVEIT
flttid has beeii diltited I : 5 with saliiie. In this case lysis is inhibited up to I.5)
minutes at 20' C. with the 5-dav fluid. -NN,hile the 12-day fluid manages to inhibit zn
lvsis for up to 30 minutes. The findinas with the other 3 sera were similar. n
TABLE II.-The Efl'ect of Serunt Dilution on the Inhib-itory Action of
Tumour A,,qcitic Flqtid on fhe Oncolytic Reaction
no lysis
= soine lysis
I-, complete lysis
Reactaiits (I : I : 1)
AF ascit-ic fltii(I
Oncolytic activity
Temp. 'C.
r -"%
20 37
Time (min.)
15 30 45 60 30 60
-1 1-
(1) saline
(2) 5-day AF
(3) a'-day (I : 5)
(4) 12-day AF
(5)) 12-dav (I : .5))
Tuiiiotir
cell
suspension
I : 20
Seruiii
dil.
I : (O
r--
I
3
4
--f-
--L- -1
I : 2 1 : 20 1
2
3
4
I : 4 1 : 20
1 : 9 I : 20
1
2
3
4
0
1
2
3
4
5
Table 11 agaiii shows the results -%N-ith serum No. 4 when undiluted serum is
used. This serum was highly lvtic so the inhibitorv effect of the ascitic fluid.
though evident, is onlv marked with the 12-day undiluted ascitic fluid. How-
ever. as the rest of the table shows. serial dilution of the serum which reduces
its lytic activity (Hartveit, 1965b), reveals the inhibitory effects of the ascitic
fluids and once again confirms. for example with the I : 2 serum dilutioli and
I : 5 ascitic fluid dilution, that the inhibitory effect of 5-day ascitic fluid is less
than that of the 12-day ascitic fluid as the formerpermitted Ivsis after 15 minutes
at 20' C., while the latter still inhibited Ivsis at 30 minutes.
The results of both experimeiits show that the iiihibitor is effective at 20' C.
-aii(I at 37' C.
DISCUSSION
The preseiit experiment has demonstrated that tumour ascitic fluid from the
Ehrlich ascites carciiioma has a markedlv inhibitorv effect on the oncolytic
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sitYgested previously (Hartveit, 1965), the oiicolvtic activitv of humaii serttlii in
this system depends oti its co'mplemeiit content aiid not oii the simultaiieous
presence of a heterophil antibody, then the oiicolytic reaction produced in viti-o
is directly comparable to that seeii in early transplaiits in vivo, as in botli cases
-v%-e are dealing with the effect of complemeiit oii seiisitised cells.
Nfouse ser-tim and human serum differ in their complement coiiteiit. NVhile
hitmaii serum coiitains fair amounts ofall the four classical components ofcomple-
meiit, mouse serum contains fair amouiits ofCI, biit very low concentrations ofthe
other three componeiits (Rice and Crowsoii. 1.950). With the Ehrlich ascites
careiiioma it could be argued that it is lack of complemeiit in the ascitic fluid
that has prevented lysis in vivo. as the tumour cells lyse when more complement.
i.e. htimaii serum, is added. This problem has beeii discussed before (Hartveit,
1963b), the conclusioji reached being that it was more likelv that aii iiihibitoi-
was preseiit than that the reaction was limited bv lack of complemeiit. Ttie
preseiit experimeiit supports this view as if lack of complemeiit in the ascitic
fluid were the i-eason for lack oflysis in late transplaiits in vivo the ascitic fluid
should have iio iiihibitiiig effect oii the oncolytic reactioii in vitro.
In addition it has beeii shown that this tumour ascitic fluid does iiot lack
CI-i.e. it, caii be fullv complemented in the immtiiie haemolytic system bv the
additioii of RI, and ftirthermore the ascitic fluid is not aiiticomplimeiitary in
that system (Hartveit. 1964). If Cl is preseiit the oiicolytic reactioii can start
aiid Ci will be used upIeven in the absence of the other compoiieiits. So, as some
CI is still present.. lack of the last three components caniiot explaiii the lack of
lvsis in vivo. This agaiii is in accordance with the findiiig in the present experi-
ment that an inhibitor oflysis is preseiit in the tumotir ascitic fluid. The identity
of this- inhibitor and its mode of actioii remaiii to be determiiied.
SUMMARY
The preseiiee of aii iiiiiibitor oflysis in the ascitic fluid from the Elirlieli ascites
careiiioma is demonstrated in aii oncolvtic system coiisistiiig of Ehrlich ascites
carcinoma cells aild humaii serum. fhe activitv of this iiihibitor appears to
iiierease with the age of the tiimour transplaiit from which it is, taken. It is
active at both 20 and 37' C.
I -%vould like to thaiik Professor E. Waalei-, Rea(l of this Institute. for his-
advice on this work.
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